Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders
US11596657B2 · kind B2 · utility
0Cited by
2References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 11, 2017 |
| Grant date | Mar 7, 2023 |
| Priority date | — |
| Expiry date | Jul 23, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the preventive or curative treatment of metabolic syndrome and the associated disorders with AhR agonist or microorganism producing AhR agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.